Navigation Links
UTAS Visual Diagnostic System

ProductsUTAS Visual Diagnostic System
Company LKC Technologies, Inc.
Item UTAS Visual Diagnostic System
Features 
  • Arbitrary color flash stimuli from -60 dB to +20 dB
  • Xenon flash (white) stimuli from 0 dB to +30 dB
  • Background luminance to 5000 cd/m2 in any color
  • ISCEV Standard ERG / EOG / VEP
  • Double flash, ON/OFF, S-Cone, photopic negative response ERG
  • Sunburst Color LED Ganzfeld
  • Sweep VEP (objective visual acuity) option
  • GLP (21 CFR11) Compliance Pack option
  • Color or white-only mini-ganzfeld option
  • CE, CB, ISO 13485:2003
Description This revolutionary product will provide you with everything you need for any type of electroretinogram, visual evoked potential, or electro-oculogram. The ultra-bright color LED ganzfeld will allow you to perform ERGs you never imagined possible including on-off, double flash, photopic negative response, and s-cone ERGs. Wireless amplification featuring our patented digital DC amplifiers allows completely faithful reproduction of every nuance of your recordings.
Info LKC Technologies, Inc.Call LKC Technologies, Inc. to buy products (US and Canada only; other locations use number below) USACanada1-866-407-6130

Customer Service: 1-800-638-7055
Web site: http://www.lkc.com

Related medicine products :

1. Vision Monitor Visual electrophysiology
2. Vision Monitor Visual Electrophysiology: MonEl1
3. Vision Monitor Visual Electrophysiology: MonEl2
4. Humphrey FDT Visual Field Instrument
5. Espion Visual Electrophysiology System
6. AT20R Visual Function Tester
7. S-Series Cystourethroscope Visual Obturator
8. USA Elite System™ Visual Urethrotome Kit
9. USA Elite System™ Visual Urethrotome
10. Harmony™ Lux Advantage LA Surgical Lighting and Visualization System
11. Near Point Diagnostic Card Set - BC11982
Breaking Medicine Technology:For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 2For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 3Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference 2Merieux Alliance Becomes Institut Merieux 2Merieux Alliance Becomes Institut Merieux 3Merieux Alliance Becomes Institut Merieux 4Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 1Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 2Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 3Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 4Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 5Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 6Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 7TCT 2009 to Feature vProtect 28TM 29 Luminal Shield a Novel Treatment Designed for Soft Coronary Lesions from Prescient Medical 14134 1TCT 2009 to Feature vProtect 28TM 29 Luminal Shield a Novel Treatment Designed for Soft Coronary Lesions from Prescient Medical 14134 2Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 1Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 2Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 3Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 4Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 5Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 6Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 7